10.1016/j.ultrasmedbio.2021.04.024 Summary Keywords arrhythmia, astragaloside IV, traditional Chinese medicine, Astragalus membranaceus , pharmacological mechanisms Citation Chen M, Fu B, Zhou H and Wu Q (2025) Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review
SGLT-2 inhibitors are a class of drugs that prevent kidney reabsorption of sugar and thus lower blood sugar levels
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased in 2.5 mg increments to a target dose of 5-15 mg based on glycemic control and tolerability
A B12 shot injection can be an excellent alternative for achieving and sustaining healthy levels
Glucagon is a hormone that causes the liver to release its stored sugar into the bloodstream
Long-term persistence of immune activation and proinflammation with latent and overt autoimmunity are etiological factors in clinical manifestation(s) of PASC 233